Icosavax
Seattle, US · Founded 2017 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
PK
Peter KolchinskyDirector
CR
Charles RichardsonSenior Vice President, Technical Operations
MM
Mark McDadeDirector
TG
Terry GouldDirector
AK
Adam K. SimpsonPresident and Chief Executive Officer
EM
Eric MoessingerDirector
NK
Niranjan Kanesa-thasanChief Medical Officer
DA
Douglas A. HoltzmanChief Scientific Officer and Secretary
JH
Jason HaflerDirector
CC
Cassia CearleyTreasurer, Chief Business Officer
TY
Tadataka Yamada, M.D.Chairman of the Board
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$99.7MraisedApr 2021 · 36 investors · BiotechnologyRule 506(b)
▶$99.7MraisedApr 2021 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KolchinskyDirector
- Charles RichardsonExecutive Officer
- Mark McDadeDirector
- Terry GouldDirector
- Adam K. SimpsonDirector, Executive Officer
- Eric MoessingerDirector
- Niranjan Kanesa-thasanExecutive Officer
- Douglas A. HoltzmanExecutive Officer
- Jason HaflerDirector
- Cassia CearleyExecutive Officer
- Tadataka Yamada, M.D.Director
- Offering amount
- $99.7M
- Amount sold
- $99.7M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$30MraisedOct 2019 · 22 investors · BiotechnologyRule 506(b)
▶$30MraisedOct 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Terry GouldDirector
- Jason HaflerDirector
- Eric MoessingerDirector
- Niranjan Kanesa-thasanExecutive Officer
- Adam K. SimpsonExecutive Officer, Director
- Mark McDadeDirector
- Charles RichardsonExecutive Officer
- Douglas A. HoltzmanExecutive Officer
- Tadataka Yamada, M.D.Director
- Offering amount
- $51M
- Amount sold
- $30M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.